Malin Corporation plc (MLC) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases.

Total Assets Chart for Malin Corporation plc

Malin Corporation plc (MLC) total assets for FY2024 were EUR 198.5M, a 70.2% change from FY2023. Malin Corporation plc's total assets grew from EUR 424.2M in 2015 to EUR 198.5M in 2024 (-53.2% over 9 years). Total assets compound annual growth rate: 5-year CAGR of -6.1%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (Euros)

R&D as % of Revenue

Key Stats

Market Cap
€30.28M
Implied Share Price
€7.00
Enterprise Value
-€31.82M
Revenue (TTM)
€41.00M
EBITDA
-€2.40M
Profit Margin
0.00%
Trailing P/E
0.00
Forward P/E
0.00
Price/Book (MRQ)
0.16
Price/Sales (TTM)
6.18
EV/EBITDA
186.08
EV/Revenue
6.08
Dividend Yield
—
Book Value
€8.90
Free Cash Flow (FY2024)
-€1.30M
Free Cash Flow Yield
-4.29%

Snapshot as of 15th August 2026 — not point-in-time controlled, may lag the live market by a few days.